PAM50 breast cancer subtypes and survival of patients in rural Ethiopia without adjuvant treatment: a prospective observational study
The OS was very low in the patient cohort that received no (neo)adjuvant treatment. Immunohistochemistry and GEP confirmed endocrine-sensitive tumours in more than half of the patients, with a large proportion of Luminal B, HER2-enriched and Basal-like tumours so that adjuvant chemotherapy should be recommended.
Authors
- Martina Vetter (ORCID: https://orcid.org/0000-0002-6642-9585)
- Claudia Wickenhauser (ORCID: https://orcid.org/0000-0002-1807-5575)
- Sefonias Getachew (ORCID: https://orcid.org/0000-0001-9506-1196)
- Tariku W. Kenea (ORCID: https://orcid.org/0009-0003-0502-5880)
- Pablo Santos (ORCID: https://orcid.org/0000-0002-3008-014X)
- Marcus Bauer (ORCID: https://orcid.org/0000-0002-0657-6831)
- Adamu Addissie (ORCID: https://orcid.org/0000-0003-4709-3606)
- Kathrin Stückrath (ORCID: https://orcid.org/0000-0002-4862-175X)
- Christian Reibold
- Pia Eber-Schulz
- Eva Johanna Kantelhardt (ORCID: https://orcid.org/0000-0001-7935-719X)
- Hannes-Viktor Ziegenhorn
- Jona Ballé
Institutions
- University Hospital Carl Gustav Carus (DE)
- Addis Ababa University (ET)
- Martin Luther University Halle-Wittenberg (DE)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-09-10
- DOI
- https://doi.org/10.1186/s12885-024-12867-6
- Citations
- 1
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.29
Funders
- Addis Ababa University